Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole Add-on for Antipsychotic-Induced Metabolic and Endocrine Side Effects
NCT00541554Phase 4Unknown
- Sponsor
- Genovate Biotechnology
- Start
- Oct 2007
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of aripiprazole in hyperprolactinemia, dyslipidemia and hyperglycemia, sponsored by Genovate Biotechnology. Status: unknown.
02
Drugs
aripiprazole
03
Conditions
hyperprolactinemiadyslipidemiahyperglycemia
Beyond the preview
Go deeper on NCT00541554.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00541554.